Skip to content
Trial Eligibility
Menu

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

NCT05856773

This study is recruiting at 9 US sites in 7 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks) compared with a longer, standard course of treatment (5 weeks) for women with breast cancer who require radiotherapy to the breast/chest wall and regional lymph nodes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
19 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Proton Collaborative Group
Last updated on ClinicalTrials.gov
September 29, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Mayo Clinic · Scottsdale, AZ

California · 1

  • California Protons Cancer Therapy Center · San Diego, CA

Florida · 3

  • University of Florida Proton Therapy Institute · Jacksonville, FL
  • Dwoskin Proton Therapy Center · Miami, FL
  • Miami Cancer Institute · Miami, FL

Georgia · 1

  • Emory Proton Therapy Center · Atlanta, GA

Maryland · 1

  • Maryland Proton Treatment Center · Baltimore, MD

New York · 1

  • New York Proton Center · New York, NY

Virginia · 1

  • Inova Schar Cancer Institute · Fairfax, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.